Read + Share
Gordon KB, Lebwohl M, Papp KA, Bachelez H, et al. Long-Term Safety of Risankizumab From 17 Clinical Trials in Patients With
Moderate-to-Severe Plaque Psoriasis. Br J Dermatol 2021 Oct 15. doi: 10.1111/bjd.20818.
PMID: 34652810
|
 |
|
Gordon KB, Lebwohl M, Papp KA, Bachelez H, et al. Long-Term Safety of Risankizumab From 17 Clinical Trials in Patients With
Moderate-to-Severe Plaque Psoriasis. Br J Dermatol 2021 Oct 15. doi: 10.1111/bjd.20818.
PMID: 34652810
|
|
|
|